
Elucidata is a TechBio company that transforms drug discovery by integrating diverse biomedical data through its AI-powered cloud platform, Polly. Polly harmonizes multi-modal biomedical data including clinical, omics, and imaging data into machine learning-ready formats, accelerating R&D and enabling faster, cost-efficient drug discovery and development. The platform supports over 26 data types and 30+ bioinformatics pipelines, ensuring data security and compliance with SOC2, HIPAA, and GDPR standards. Elucidata offers managed services such as data curation, pipeline building, and custom app development, serving biopharma innovators to streamline data workflows and optimize research outcomes. Trusted by leading biopharma companies, Elucidata delivers scalable, AI-driven insights that improve target identification, biomarker discovery, patient stratification, and diagnostics workflows, achieving significant cost savings and faster model development in precision medicine and translational research.

Elucidata is a TechBio company that transforms drug discovery by integrating diverse biomedical data through its AI-powered cloud platform, Polly. Polly harmonizes multi-modal biomedical data including clinical, omics, and imaging data into machine learning-ready formats, accelerating R&D and enabling faster, cost-efficient drug discovery and development. The platform supports over 26 data types and 30+ bioinformatics pipelines, ensuring data security and compliance with SOC2, HIPAA, and GDPR standards. Elucidata offers managed services such as data curation, pipeline building, and custom app development, serving biopharma innovators to streamline data workflows and optimize research outcomes. Trusted by leading biopharma companies, Elucidata delivers scalable, AI-driven insights that improve target identification, biomarker discovery, patient stratification, and diagnostics workflows, achieving significant cost savings and faster model development in precision medicine and translational research.
Product: Polly — AI-ready biomedical data platform that harmonizes multi-modal data for drug discovery
Founded: 2015
Headquarters: San Francisco, California
Compliance: SOC2, HIPAA, GDPR
Recent disclosed round: Series A (Sep 27, 2022)
| Company |
|---|
Biomedical data integration and preparation for AI/ML in drug discovery, translational research, and diagnostics.
2015
Software Development
“Investors include Eight Roads Ventures, F-Prime, Hyperplane, IvyCap Ventures, IBOS ventures, TiE SoCal Angels, Zephyrmind”